Patent Assignment
Reel/Frame 026839/0241
Assignment of Assignor's Interest
Recorded: 2011-08-31
Pages: 17
Assignors
ROSKAMP FOUNDATION IRREVOCABLE TRUST D/B/A ROSKAMP INSTITUTE
Executed: 2011-07-05
ROSKAMP RESEARCH LLC
Executed: 2011-07-05
ARCHER PHARMACEUTICALS, INC.
Executed: 2011-07-15
Assignee
ALZHEIMER'S INSTITUTE OF AMERICA, INC.
1300 NORTH 78TH STREET, KANSAS CITY, KANSAS, 66112
Covered Properties
(6)
Modulation of the Phospholipase A2 Pathway as a Therapeutic
Patent:
7,605,149 →
Application:
09/743,781 →
Inhibition of Angiogenesis by a-Beta Peptides
Modulation of Angiogenesis by a-Beta Peptide Fragments
Compounds for Inhibiting Beta-Amyloid Production
Application:
12/278,341 →
Publication:
US 2009/0017112
Modulation of Angiogenesis by a-Beta Peptide Fragments
Application:
12/471,279 →
Publication:
US 2010/0130416
Polyhydroquinoline Compounds and Dihydropyridine Compounds for Inhibiting Beta-Amyloid Production
Application:
12/518,251 →
Publication:
US 2010/0119599
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2005
From: THE UNIVERSITY OF SOUTH FLORIDA
To: ROSKAMP RESEARCH LLC
Reel/Frame 015621/0835 →
Assignment of Assignor's Interest
Aug 10, 2007
From: PARIS, DANIEL; MULLAN, MICHAEL J.
To: ROSKAMP RESEARCH LLC
Reel/Frame 019677/0124 →
Assignment of Assignor's Interest
Aug 27, 2008
From: MULLAN, MICHAEL J.; PARIS, DANIEL; BAKSHI, PANCHAM
To: ROSKAMP RESEARCH LLC
Reel/Frame 021451/0262 →
Assignment of Assignor's Interest
Feb 13, 2017
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 041233/0541 →
Grant of Security Interest in United States Patents
Feb 13, 2017
From: ARCHER PHARMACEUTICALS, INC.
To: AIA AMERICA, INC.
Reel/Frame 041689/0945 →